(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PROVOLUT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PROVOLUT

ST13

US500000099266882

Class

9, 42

Filing

99266882

Registration

8290852

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

07/29/2026

Trademark type

Word

Nice classes

9, 42

Filing date

07/03/2025

Registration date

06/09/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/09/2026

Last transaction

07/29/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

27

Owner location

Berlin, DE

Examiner

JONES, JACQUELYN ANDREA

Law office

N20

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Exazyme GmbH

Representatives

KATRIN LEWERTOFF LEWERTOFF IP LAW GROUP, LLC

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Recorded and downloadable media and datarecorded and downloadable datasets comprising protein sequencestructurefunction data for use in biotechnology and pharmaceutical research; Downloadable databases in the field of protein engineeringmolecular biologydrug discovery; Downloadable software for computational protein designprotein engineeringmolecular simulationoptimization of proteinsenzymesmolecules for pharmaceutical and industrial biotechnology applications; Downloadable artificial intelligence software for protein designprotein optimizationdrug candidate identificationprediction of protein properties and downloadable software using machine learning for designinganalyzingoptimizingpredicting the function and properties of proteinsenzymesmolecules for use in pharmaceutical development and biotechnology; all the aforesaid goods relating toin particularsynthetic biologybiotechnologyprotein engineeringmolecular sciences and the designdevelopment and optimization of proteinsenzymes and molecules

Class 42

IT servicesIT consulting services relating to the implementationintegrationmaintenancecustomization of software for computational biologyprotein engineeringdrug design; developmentprogramming and implementation of software for others; hosting serviceshosting cloud-based software platforms for computational protein designmolecular simulationdrug discovery; platform-as-a-service (PaaS) featuring computer software platforms for computational protein engineeringmachine-learning-driven protein optimizationpharmaceutical drug candidate design and analysis; software-as-a-service (SaaS) services featuring software for AI-driven protein designprotein optimizationmolecular engineeringdrug discovery; rental of computer software for computational protein designprotein optimizationmolecular simulationdrug development; design and development of computer hardware and software; scientific and technological servicesscientific researchcomputational analysistesting in the field of protein engineeringmolecular biologydrug discoverybiotechnology and scientific and technological research in the field of protein designenzyme engineeringdrug developmentprecision oncology and design services relating theretocomputational protein designenzyme designdrug candidate designsoftware design for biotechnology applications; industrial research in the field of biotechnologyprotein engineeringindustrial enzyme development and industrial design services; quality control of goods and services and authentication in the field of protein and enzyme qualitypharmaceutical drug candidatesbiotechnological products; development of pharmaceutical products; Scientific laboratory services; laboratory research in the field of protein engineeringmolecular biologyenzyme optimizationpharmaceutical drug development; Scientific laboratory services; Computer software consultancyinformation and information services in the field of computational biologyprotein engineeringdrug designbiotechnology relating to the aforementioned services; all of the aforementioned servicesin particularin the field of synthetic biologybiotechnologyprotein technologymolecular sciences and for the designdevelopment and optimization of proteinsenzymes and molecules

Publications

History of USPTO decisions and trademark events.

17 publications found

ES7R

TEAS SECTION 7 REQUEST RECEIVED

07/29/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/09/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

06/09/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/21/2026

PUBO

PUBLISHED FOR OPPOSITION

04/21/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/15/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/24/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/24/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/24/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/24/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/24/2025

GNRT

NON-FINAL ACTION E-MAILED

11/24/2025

CNRT

NON-FINAL ACTION WRITTEN

11/24/2025

DOCK

ASSIGNED TO EXAMINER

11/21/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/09/2025

MAFR

APPLICATION FILING RECEIPT MAILED

07/03/2025

NWAP

NEW APPLICATION ENTERED

07/03/2025

Continuous trademark protection

Get notified about every new filing that threatens PROVOLUT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.